Allopurinol
A xanthine oxidase inhibitor that lowers uric acid production and is widely used in long-term management of gout and hyperuricemia.
The importance of Allopurinol comes from the fact that it involves immune recognition, hypersensitivity, immune deficiency or donor-recipient responses.
To characterize Allopurinol, history and examination may be supplemented by antibody studies, allergy testing, immune assays or tissue compatibility testing.
Management is not uniform: management depends on the immune mechanism and can include avoidance, medication, immunotherapy or specialist monitoring.
Its prognosis and urgency cannot be judged from the term alone; associated symptoms, comorbidities and objective findings determine the next step.
Medical advice is especially important if features linked with allopurinol are new, worsening or affecting normal function.
To characterize Allopurinol, history and examination may be supplemented by antibody studies, allergy testing, immune assays or tissue compatibility testing.
Management is not uniform: management depends on the immune mechanism and can include avoidance, medication, immunotherapy or specialist monitoring.
Its prognosis and urgency cannot be judged from the term alone; associated symptoms, comorbidities and objective findings determine the next step.
Medical advice is especially important if features linked with allopurinol are new, worsening or affecting normal function.
This information is for general awareness only and is not medical advice. Consult a doctor for any health concern.